Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Fallopian Tube Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Peritoneal+Cavity%22&type=Subject&filter%5B%5D=topic_facet%3A%22Fallopian+Tube+Neoplasms%22
/vufind/Search/Results?lookfor=%22Peritoneal+Cavity%22&type=Subject&filter%5B%5D=topic_facet%3A%22Fallopian+Tube+Neoplasms%22
Search /vufind/Search2/Results?lookfor=%22Peritoneal+Cavity%22&type=Subject&filter%5B%5D=topic_facet%3A%22Fallopian+Tube+Neoplasms%22
PubPharm (55)
1
Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer : A Phase I/II Trial of Weekly Paclitaxel In Combination With Ganetespib In Patients With Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
2
Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer : Evaluation of the Immunogenicity of Vaccination With Synthetic Peptides in Adjuvant in Patients With Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
3
Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer : A Phase I Clinical Trial of NY-ESO-1 Protein Immunization in Combination With 5-AZA-2'-Deoxycytidine (Decitabine) in Patients Receiving Liposomal Doxorubicin for Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
4
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer : A Randomized Multicenter Study to Compare the Efficacy of Additional Tumor Debulking Surgery vs Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
5
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer : A Phase I Clinical Trial of mTOR Inhibition With Sirolimus for Enhancing ALVAC(2)-NY-ESO-1(M)/TRICOM Vaccine Induced Anti-Tumor Immunity in Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
6
Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer : A Pilot Trial to Study the Availability and Effect of Post-OP IV Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer, Cells Retrieved From the Peritoneal Cavity
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
7
Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission : A Randomized Phase III Trial in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer With a Polyvalent Vaccine-KLH Conjugate + OPT-821 Versus OPT-821
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
8
Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer : A Pilot Trial to Evaluate the Feasibility Auranofin (Ridaura®) for Asymptomatic Patients With First-Recurrence Epithelial Ovarian Cancer
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
9
Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer : A Phase II Evaluation of CCI-779 (Temsirolimus, NCI-Supplied Agent, NSC #683864, IND #61010) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
10
Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin : A Phase II Evaluation of Belinostat (NSC #726630) and Carboplatin (NSC #241240) in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
1
2
3
4
5
6
Nächster »
[6]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Fallopian Tube Neoplasms
Medienart
55
Aufsätze
55
E-Artikel
55
E-Ressourcen
Zeitschriftentitel
55
ClinicalTrials.gov
Thema
55
610
Fallopian Tube Neoplasms
51
Study Type: Interventional
36
Carcinoma, Ovarian Epithelial
29
Recruitment Status: Completed
26
Phase: Phase 2
18
Peritoneal Neoplasms
16
Medical Condition: Fallopian Tube Cancer, Ovari...
16
Recruitment Status: Terminated
14
Medical Condition: Fallopian Tube Cancer, Ovari...
14
Ovarian Neoplasms
12
Phase: Phase 1
6
Breast Neoplasms
6
Endometrial Neoplasms
6
Recruitment Status: Unknown status
5
Carcinoma
5
Medical Condition: Recurrent Fallopian Tube Can...
5
Sarcoma
5
Vaginal Neoplasms
5
Vulvar Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2020-
48
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
55
Englisch
Haven't found what you're looking for?
Wird geladen...